A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.

B-chronic lymphocytic leukemia (B-CLL), the most common human leukemia, is characterized by predominantly non-dividing malignant mature CD5+ B lymphocytes with an apoptosis defect. Various microenvironmental stimuli confer a growth advantage on these leukemic cells and extend their survival in vivo....

Full description

Bibliographic Details
Main Authors: Hussein Ghamlouch, Hakim Ouled-Haddou, Gandhi Damaj, Bruno Royer, Brigitte Gubler, Jean-Pierre Marolleau
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3608602?pdf=render
_version_ 1811233606560907264
author Hussein Ghamlouch
Hakim Ouled-Haddou
Gandhi Damaj
Bruno Royer
Brigitte Gubler
Jean-Pierre Marolleau
author_facet Hussein Ghamlouch
Hakim Ouled-Haddou
Gandhi Damaj
Bruno Royer
Brigitte Gubler
Jean-Pierre Marolleau
author_sort Hussein Ghamlouch
collection DOAJ
description B-chronic lymphocytic leukemia (B-CLL), the most common human leukemia, is characterized by predominantly non-dividing malignant mature CD5+ B lymphocytes with an apoptosis defect. Various microenvironmental stimuli confer a growth advantage on these leukemic cells and extend their survival in vivo. Nevertheless, when cultured in vitro, CLL B-cells rapidly die from apoptosis. Certain cytokines may extend the survival capacity of CLL B-cells in vitro and individual anti-apoptotic effects of several cytokines have been reported. The potential cumulative effect of such cytokines has not been studied. We therefore investigated the effects on CLL B-cells survival in vitro of humoral factors, polyclonal lymphocyte activators and a combination of cytokines known for their anti-apoptotic effects. Purified CLL B-cells were cultured in the presence or absence of various soluble molecules and the leukemic cell response was assessed in terms of viability. Apoptotic cell death was detected by flow cytometry using annexinV and 7-amino-actinomycin. The survival of CLL B-cells in vitro was highly variable. When tested separately, cytokines (IL-2, -6, -10, -12, -15, -21, BAFF and APRIL) improved CLL B cell survival moderately; in combination, they significantly enhanced survival of these cells, even up to 7 days of culture. We also report that humoral factors from autologous serum are important for survival of these malignant cells. Our findings support the concept that the CLL microenvironment is critical and suggest that soluble factors may contribute directly to the prolonged survival of CLL B-cells. Therefore, the combination of cytokines we describe as providing strong resistance to apoptosis in vitro might be used to improve the treatment of CLL.
first_indexed 2024-04-12T11:22:37Z
format Article
id doaj.art-dd77e1d06f0e4b24a2cebb3387257ae6
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T11:22:37Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-dd77e1d06f0e4b24a2cebb3387257ae62022-12-22T03:35:20ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0183e6037010.1371/journal.pone.0060370A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.Hussein GhamlouchHakim Ouled-HaddouGandhi DamajBruno RoyerBrigitte GublerJean-Pierre MarolleauB-chronic lymphocytic leukemia (B-CLL), the most common human leukemia, is characterized by predominantly non-dividing malignant mature CD5+ B lymphocytes with an apoptosis defect. Various microenvironmental stimuli confer a growth advantage on these leukemic cells and extend their survival in vivo. Nevertheless, when cultured in vitro, CLL B-cells rapidly die from apoptosis. Certain cytokines may extend the survival capacity of CLL B-cells in vitro and individual anti-apoptotic effects of several cytokines have been reported. The potential cumulative effect of such cytokines has not been studied. We therefore investigated the effects on CLL B-cells survival in vitro of humoral factors, polyclonal lymphocyte activators and a combination of cytokines known for their anti-apoptotic effects. Purified CLL B-cells were cultured in the presence or absence of various soluble molecules and the leukemic cell response was assessed in terms of viability. Apoptotic cell death was detected by flow cytometry using annexinV and 7-amino-actinomycin. The survival of CLL B-cells in vitro was highly variable. When tested separately, cytokines (IL-2, -6, -10, -12, -15, -21, BAFF and APRIL) improved CLL B cell survival moderately; in combination, they significantly enhanced survival of these cells, even up to 7 days of culture. We also report that humoral factors from autologous serum are important for survival of these malignant cells. Our findings support the concept that the CLL microenvironment is critical and suggest that soluble factors may contribute directly to the prolonged survival of CLL B-cells. Therefore, the combination of cytokines we describe as providing strong resistance to apoptosis in vitro might be used to improve the treatment of CLL.http://europepmc.org/articles/PMC3608602?pdf=render
spellingShingle Hussein Ghamlouch
Hakim Ouled-Haddou
Gandhi Damaj
Bruno Royer
Brigitte Gubler
Jean-Pierre Marolleau
A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.
PLoS ONE
title A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.
title_full A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.
title_fullStr A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.
title_full_unstemmed A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.
title_short A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.
title_sort combination of cytokines rescues highly purified leukemic cll b cells from spontaneous apoptosis in vitro
url http://europepmc.org/articles/PMC3608602?pdf=render
work_keys_str_mv AT husseinghamlouch acombinationofcytokinesrescueshighlypurifiedleukemiccllbcellsfromspontaneousapoptosisinvitro
AT hakimouledhaddou acombinationofcytokinesrescueshighlypurifiedleukemiccllbcellsfromspontaneousapoptosisinvitro
AT gandhidamaj acombinationofcytokinesrescueshighlypurifiedleukemiccllbcellsfromspontaneousapoptosisinvitro
AT brunoroyer acombinationofcytokinesrescueshighlypurifiedleukemiccllbcellsfromspontaneousapoptosisinvitro
AT brigittegubler acombinationofcytokinesrescueshighlypurifiedleukemiccllbcellsfromspontaneousapoptosisinvitro
AT jeanpierremarolleau acombinationofcytokinesrescueshighlypurifiedleukemiccllbcellsfromspontaneousapoptosisinvitro
AT husseinghamlouch combinationofcytokinesrescueshighlypurifiedleukemiccllbcellsfromspontaneousapoptosisinvitro
AT hakimouledhaddou combinationofcytokinesrescueshighlypurifiedleukemiccllbcellsfromspontaneousapoptosisinvitro
AT gandhidamaj combinationofcytokinesrescueshighlypurifiedleukemiccllbcellsfromspontaneousapoptosisinvitro
AT brunoroyer combinationofcytokinesrescueshighlypurifiedleukemiccllbcellsfromspontaneousapoptosisinvitro
AT brigittegubler combinationofcytokinesrescueshighlypurifiedleukemiccllbcellsfromspontaneousapoptosisinvitro
AT jeanpierremarolleau combinationofcytokinesrescueshighlypurifiedleukemiccllbcellsfromspontaneousapoptosisinvitro